Related Experiment Video
Updated: Dec 14, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
An update on biological therapies for pediatric allergic diseases
Riccardo Castagnoli1, Maria De Filippo1, Martina Votto1
1Department of Pediatrics, Pediatric Clinic, IRCCS San Matteo Polyclinic Foundation, University of Pavia, Pavia, Italy.
Insights
Biologic therapies show promise for treating pediatric allergic diseases like asthma and atopic dermatitis. This review examines the efficacy and safety of these advanced treatments for children.
Area of Science:
- Pediatric Allergy and Immunology
- Immunotherapy
- Pharmacology
Background:
- Allergic diseases pose a significant global health challenge, impacting quality of life.
- Severe allergic conditions can lead to disability, emotional distress, and social limitations.
- Understanding disease pathogenesis is key to developing new treatments.
Purpose of the Study:
- To review current evidence on biologic therapies for pediatric allergic diseases.
- To focus on the efficacy and safety of these treatments in children.
- To explore applications beyond allergic asthma.
Main Methods:
- Systematic review of recent scientific literature.
- Analysis of clinical trial data on biologic drugs.
- Focus on studies involving pediatric populations.
Main Results:
- Biologic drugs demonstrate strong efficacy and safety in pediatric allergic asthma.
- Promising results are emerging for atopic dermatitis, chronic spontaneous urticaria, and food allergy.
- Evidence supports the expanding role of biologics in managing childhood allergies.
Conclusions:
- Biologic therapies represent a significant advancement in managing pediatric allergic diseases.
- Further research is warranted to broaden the application of these treatments.
- These therapies offer new hope for improving outcomes in children with allergies.
Abstract:
Allergic diseases represent a global health burden. Patients with allergic diseases may experience disability, reduced quality of life and productivity, emotional distress, and social restrictions, especially in the most severe cases. Current advances in unveiling the pathogenesis of allergic disorders have paved the way for the development of novel therapeutic strategies. Biological drugs have been widely studied in pediatric allergic asthma, with strong evidence of efficacy and safety. Moreover, promising results derive from studies on other conditions such as atopic dermatitis, chronic spontaneous urticaria, and food allergy. This review analyzes recent evidence on the role of biologic therapies for allergic diseases, focusing on the pediatric age.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Allergic Reactions
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Allergic Drug Reactions
Microorganisms in Medicine and Therapeutics

